Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma

Clinical trial NCT00884741 · COMPLETED

Trial details

NCT number: NCT00884741
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Glioblastoma Gliosarcoma Supratentorial Glioblastoma

Start date: 2009-04-15
Primary completion: 2013-03-17
Enrollment: 637

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.